Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.

We aimed to evaluate the additive value of cardiovascular magnetic resonance imaging (CMR) and cardiopulmonary exercise test (CPET) to predict clinical outcomes in patients with HCM. We enrolled 373 patients with HCM and normal left ventricular systolic function who underwent CPET and CMR. The prima...

Full description

Bibliographic Details
Main Authors: Ji-Won Hwang, Sang-Chol Lee, Darae Kim, Jihoon Kim, Eun Kyoung Kim, Sung-A Chang, Sung-Ji Park, Sung Mok Kim, Yeon Hyeon Choe, Seung Woo Park
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0285887
_version_ 1797802032379199488
author Ji-Won Hwang
Sang-Chol Lee
Darae Kim
Jihoon Kim
Eun Kyoung Kim
Sung-A Chang
Sung-Ji Park
Sung Mok Kim
Yeon Hyeon Choe
Seung Woo Park
author_facet Ji-Won Hwang
Sang-Chol Lee
Darae Kim
Jihoon Kim
Eun Kyoung Kim
Sung-A Chang
Sung-Ji Park
Sung Mok Kim
Yeon Hyeon Choe
Seung Woo Park
author_sort Ji-Won Hwang
collection DOAJ
description We aimed to evaluate the additive value of cardiovascular magnetic resonance imaging (CMR) and cardiopulmonary exercise test (CPET) to predict clinical outcomes in patients with HCM. We enrolled 373 patients with HCM and normal left ventricular systolic function who underwent CPET and CMR. The primary outcome was a clinical composite of all-cause death, cardiac transplantation, stroke, heart failure requiring hospitalization and defibrillator implantation. During a follow-up of 70.70 ± 30.74 months, there were 84 composite clinical events. Peak oxygen consumption during CPET was significantly lower (18.51±13.25 vs. 24.59±13.28 mL/kg/min, p < 0.001) and abnormal hemodynamic response to exercise was more frequently detected (41.7 vs. 20.8%, p<0.001) in the group with composite clinical events. The extent of late gadolinium enhancement was larger in the event group (15.39±10.53 vs. 11.97±9.53%LV, p<0.001). Selective parameters were added stepwise to conventional clinical parameters; the final model, where CPET and CMR parameters were added, was verified to have the highest increment value for clinical outcome prediction (p<0.001). This study demonstrated that CPET and CMR findings may be important clinical tools for risk stratification in HCM. Exercise capacity was an independent predictor of composite outcomes in patients with HCM, with incremental value as a risk factor when added to the alleged parameters. These findings could help physicians monitor and manage patients with HCM in the real clinical field.
first_indexed 2024-03-13T04:59:35Z
format Article
id doaj.art-4c45f4ade1c244948e87e66dcb3e03aa
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-13T04:59:35Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4c45f4ade1c244948e87e66dcb3e03aa2023-06-17T05:31:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01185e028588710.1371/journal.pone.0285887Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.Ji-Won HwangSang-Chol LeeDarae KimJihoon KimEun Kyoung KimSung-A ChangSung-Ji ParkSung Mok KimYeon Hyeon ChoeSeung Woo ParkWe aimed to evaluate the additive value of cardiovascular magnetic resonance imaging (CMR) and cardiopulmonary exercise test (CPET) to predict clinical outcomes in patients with HCM. We enrolled 373 patients with HCM and normal left ventricular systolic function who underwent CPET and CMR. The primary outcome was a clinical composite of all-cause death, cardiac transplantation, stroke, heart failure requiring hospitalization and defibrillator implantation. During a follow-up of 70.70 ± 30.74 months, there were 84 composite clinical events. Peak oxygen consumption during CPET was significantly lower (18.51±13.25 vs. 24.59±13.28 mL/kg/min, p < 0.001) and abnormal hemodynamic response to exercise was more frequently detected (41.7 vs. 20.8%, p<0.001) in the group with composite clinical events. The extent of late gadolinium enhancement was larger in the event group (15.39±10.53 vs. 11.97±9.53%LV, p<0.001). Selective parameters were added stepwise to conventional clinical parameters; the final model, where CPET and CMR parameters were added, was verified to have the highest increment value for clinical outcome prediction (p<0.001). This study demonstrated that CPET and CMR findings may be important clinical tools for risk stratification in HCM. Exercise capacity was an independent predictor of composite outcomes in patients with HCM, with incremental value as a risk factor when added to the alleged parameters. These findings could help physicians monitor and manage patients with HCM in the real clinical field.https://doi.org/10.1371/journal.pone.0285887
spellingShingle Ji-Won Hwang
Sang-Chol Lee
Darae Kim
Jihoon Kim
Eun Kyoung Kim
Sung-A Chang
Sung-Ji Park
Sung Mok Kim
Yeon Hyeon Choe
Seung Woo Park
Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
PLoS ONE
title Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
title_full Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
title_fullStr Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
title_full_unstemmed Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
title_short Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
title_sort role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy
url https://doi.org/10.1371/journal.pone.0285887
work_keys_str_mv AT jiwonhwang roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT sangchollee roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT daraekim roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT jihoonkim roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT eunkyoungkim roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT sungachang roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT sungjipark roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT sungmokkim roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT yeonhyeonchoe roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy
AT seungwoopark roleofcardiovascularmagneticresonanceimagingandcardiopulmonaryexercisetestinpredictingcompositeclinicaloutcomesinpatientswithhypertrophiccardiomyopathy